Sam Rolfe

In an era where patients expect seamless, personalized, and trustworthy experiences, engagement has become the cornerstone of healthcare transformation. This keynote explores the cutting-edge strategies and innovations reshaping how pharma and healthcare organizations connect with patients – building lasting loyalty while advancing access, adherence, and health equity.

From AI-driven personalization and omnichannel engagement to real-time data insights and value-based patient journeys, this session reveals how leading brands are reimagining what “patient-centric” truly means today.

• Harnessing AI, predictive analytics, and connected ecosystems to deliver hyper-personalized patient experiences that stand out in an increasingly competitive digital health landscape.
• Developing inclusive strategies that simplify navigation, reduce barriers to care, and enhance adherence—ensuring every patient has equitable access to treatment and support.
• Integrating advanced engagement platforms and behavioral insights to create meaningful, trust-based interactions—transforming patients into long-term advocates and partners in care.

Pharma marketing stands at a pivotal crossroads. The old playbooks, once built on caution and convention, are giving way to a new era defined by creativity, courage, and connected intelligence. To lead in 2026 and beyond, marketers must learn to innovate fearlessly while operating with uncompromising integrity and patient trust at the core.

This provocative discussion brings together boundary-pushing leaders who are rewriting the rules of engagement—challenging the status quo, dismantling silos, and redefining how innovation can coexist with regulation. The conversation will explore how AI, data transparency, and cultural transformation are unlocking a new kind of agility in pharma marketing: one that’s bold, compliant, and deeply human.

• Courage Over Comfort: Explore how forward-thinking organizations are reframing risk as a driver of creativity and competitive edge—without compromising ethics or compliance.
• Reimagining the Marketing Blueprint: Learn how innovators are transforming traditional channels and leveraging emerging technologies to create authentic, real-time connections with HCPs and patients.
• Building Trust in the Age of Transformation: Understand how transparency, empathy, and purpose-led storytelling are redefining trust as the true currency of pharma innovation.

The future of pharma commercial engagement is omnichannel, but many companies still operate in silos. This talk will examine how to orchestrate integrated journeys that cross digital, in-person, patient and HCP touchpoints in a cohesive way.

• Mapping the combined HCP and patient journey and understanding what does true omnichannel look like in 2025 and beyond?
• Exploring technology enablers: CRM, marketing automation, data orchestration, and decision engines.
• Organizational enablers: cross-functional teams, shared KPIs, agile operating model.
• Studying examples of successful omnichannel pilots and the measurable impact on engagement and conversion.

Launching or marketing in a rare disease space demands different strategies than broad therapeutic areas. This talk covers how to engage niche HCP networks, build patient communities and operate with limited budgets but maximum impact.

• Understanding the rare disease ecosystem: patients, caregivers, advocacy groups, HCPs.
• Tailoring value messaging and learning how to articulate benefit in ultra-niche populations.
• Leveraging peer networks, micro-influencers, virtual care models.
• Exploring next-gen commercial models for rare disease where scale is small but value is high.

Creating a seamless brand experience for both patients and HCPs requires tight alignment across strategy, teams, and execution. This panel will explore how UCB unifies DTC and HCP approaches while leveraging cross-functional collaboration, diverse perspectives, and generational insights to drive stronger engagement and performance.

• Aligning DTC and HCP efforts under one brand strategy while tailoring messaging to each audience
• Clarifying the differences in engaging patients vs. HCPs to ensure relevance without fragmentation
• Embedding cross-functional collaboration into daily operations to break down silos and improve execution
• Leveraging diverse backgrounds and perspectives to strengthen creativity and audience understanding
• Promoting mentorship across experience levels to balance seasoned expertise with new thinking 

In a crowded and increasingly digital healthcare environment, effective engagement requires more than strong brand messaging—it requires a deeper understanding of the human experiences shaping both patients and healthcare providers. This executive roundtable will explore how pharma marketing and commercial leaders can use human insight to create more authentic engagement, strengthen trust, and support better patient outcomes.

• Centering engagement on real human needs by understanding patient and HCP motivations, challenges, and decision drivers
• Shifting from promotion to partnership by creating more meaningful, two-way interactions.
• Using insight and data to personalize engagement across the patient and HCP journey
• Aligning teams around value-driven engagement that prioritizes outcomes over messaging

From apps and portals to engagement hubs and chatbots, digital tools now sit at the center of the patient and HCP experience. Yet while some have boosted adherence and outcomes, many have failed: poor design, lack of interoperability, and low adoption eroding both trust and impact. This session examines what works and what doesn’t, with case studies from pharma and solutions experts, lessons from retail UX, and strategies to overcome “tool fatigue” in the customer journey. 

• Investing in tools with intuitive design, seamless interoperability, and clear value for patients and HCPs
• Applying lessons from case studies where tools drove adherence, and avoiding pitfalls that led to poor adoption
• Streamlining offerings and integrate experiences to reduce friction in the patient journey
• Adapting proven UX and engagement practices from retail and consumer health to elevate pharma’s digital experience